US 9211302
Modulation of LRCH4 activity and therapeutic application thereof
granted A61KA61K31/713A61K38/1709
Quick answer
US patent 9211302 (Modulation of LRCH4 activity and therapeutic application thereof) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 10 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/713, A61K38/1709, A61K39/3955, A61P